Lurquin; Christophe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lurquin; Christophe.The latest application filed is for "tumor antigens and ctl clones isolated by a novel procedure".

Company Profile

0.13.2

Lurquin; Christophe - Brussels BE
LURQUIN, CHRISTOPHE - BRUXELLES BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3 Grant 7,923,534 - Boon , et al. April 12, 2	2011-04-12
Tumor antigens and CTL clones isolated by a novel procedure Grant 7,351,409 - Chaux , et al. April 1, 2	2008-04-01
Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor Grant RE40,089 - Boon-Falleur , et al. February 19, 2	2008-02-19
Tumor antigens and CTL clones isolated by a novel procedure App 20040185033 - Chaux, Pascal ; et al.	2004-09-23
Tumor antigens and CTL clones isolated by a novel procedure Grant 6,710,172 - Chaux , et al. March 23, 2	2004-03-23
Recombinant Adenoviral Vectors For Human Tumour Gene Therapy App 20030082150 - BOON-FALLEUR, THIERRY ; et al.	2003-05-01
Method for treating cancer by administering MAGE-derived peptides Grant 6,488,932 - Boon , et al. December 3, 2	2002-12-03
Tumor antigens and CTL clones isolated by a novel procedure Grant 6,407,063 - Luiten , et al. June 18, 2	2002-06-18
Isolated nonapeptides which bind to HLA molecules and provoke lysis by cytolytic T cells Grant 6,034,214 - Boon , et al. March 7, 2	2000-03-07
Isolated nucleic acid molecules which are members of the MAGE-B family and uses thereof Grant 6,017,705 - Lurquin , et al. January 25, 2	2000-01-25
Tumor rejection antigen precursors, tumor rejection antigens and uses thereof Grant 5,925,729 - Boon , et al. July 20, 1	1999-07-20
Method of screening for cancer by detecting messenger RNA for a MAGE-XP gene Grant 5,759,783 - Lurquin , et al. June 2, 1	1998-06-02
Isolated nucleic acid molecules which encode MAGE derived nonapeptides Grant 5,462,871 - Boon-Falleur , et al. October 31, 1	1995-10-31
Isolated nonapeptides derived from MAGE genes and uses thereof Grant 5,405,940 - Boon , et al. April 11, 1	1995-04-11
Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 Grant 5,342,774 - Boon , et al. August 30, 1	1994-08-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.